Need for dosage adjustment during the first year of treatment with non-vitamin k oral anticoagulants in non-valvular atrial fibrillation patients

28 August 2018 (09:26 - 09:35)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Gines Elvira Ruiz

General University Hospital of Elche, Elche (Spain)

7 More presentations in this session

Presentation thumbnail

Riociguat in transthyretin cardiac amyloidosis-data from a named patient use program in austria

Doctor F. Duca (Vienna, AT)

Presentation thumbnail

The monocentric, double-blind, placebo-controlled research of sildenafil impact in pediatric patients with secondary pulmonary hypertension.

Associate Professor I. Palii (Chisinau, MD)

Abstract Slides Video

Presentation thumbnail

Obesity paradox outcomes after acute myocardial infarction in Japanese is due to optimal medical therapy in overweight patients

Assistant Professor K. Sakamoto (Kumamoto, JP)

Abstract Slides Video

Presentation thumbnail

Elucidating the underlying mechanisms for the differential response to sodium channel blocker antiarrhythmic drugs in obese patients with atrial fibrillation

Assistant Professor M. Mccauley (Chicago, US)

Abstract Slides Video

Presentation thumbnail

The impact of additional mineralocorticoid receptor antagonist on guideline-recommended medical therapy in acute heart failure patients with ischemic heart disease.

Doctor T. Abe (Kawagoe, JP)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiovascular drug therapy in special populations

The Event

ESC Congress 2018

28 August 2018 09:26 CET

You may be interested in

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

Congress Presentation

Antithrombotic therapy in diabetes

Congress Presentation

Contemporary thrombosis management -- state of the state

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources